A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension

1988 ◽  
Vol 116 (6) ◽  
pp. 1806-1814 ◽  
Author(s):  
Walter Nechwatal ◽  
Jakob Berger ◽  
Wolfgang Blumrich ◽  
Hischam Bouzo ◽  
Klaus Brandl ◽  
...  
Keyword(s):  
Essential Hypertension ◽  
Comparative Study ◽  
Moderate Essential Hypertension ◽  
Double Blind

Efficacy and tolerability profile of nebivolol vs atenolol in mild‐to‐moderate essential hypertension: Results of a double‐blind randomized multicentre trial

2003 ◽  
Vol 12 (sup2) ◽  
pp. 35-40 ◽  
Author(s):  
Guido Grassi ◽  
Fosca Quarti Trevano ◽  
Annalisa Facchini ◽  
Torakis Toutouzas ◽  
Bernard Chanu ◽  
...  
Keyword(s):  
Essential Hypertension ◽  
Multicentre Trial ◽  
Moderate Essential Hypertension ◽  
Tolerability Profile ◽  
Double Blind

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial

2001 ◽  
Vol 23 (8) ◽  
pp. 1166-1179 ◽  
Author(s):  
William J. Elliott ◽  
David A. Calhoun ◽  
Paul T. DeLucca ◽  
Lisa P. Gazdick ◽  
Dawn E. Kerns ◽  
...  
Keyword(s):  
Essential Hypertension ◽  
Moderate Essential Hypertension ◽  
Double Blind

Evaluation of the Effect of Timolol Alone and in Combination with Hydrochlorothiazide and Amiloride in the Treatment of Mild to Moderate Arterial Hypertension: A Double-Blind, Controlled Study

1976 ◽  
Vol 51 (s3) ◽  
pp. 529s-531s ◽  
Author(s):  
G. Muiesan ◽  
B. Magnani ◽  
E. Agabiti-Rosei ◽  
C. Alicandri ◽  
E. Ambrosioni ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Essential Hypertension ◽  
Side Effects ◽  
Moderate Essential Hypertension ◽  
Fixed Dose ◽  
Controlled Study ◽  
Double Blind ◽  
Combination Tablet ◽  
Group A ◽  
Group B

1. The effects of timolol alone and in combination with a fixed dose of hydrochlorothiazide and amiloride have been studied in a double-blind, controlled study in fifty-four patients with mild to moderate essential hypertension. 2. After a 4 weeks placebo period patients were randomly assigned to enter groups receiving timolol alone (group A), hydrochlorothiazide + amiloride (group B) or timolol + hydrochlorothiazide + amiloride (group C). Each treatment was carried out for 6 weeks. 3. The use of timolol (10 mg), hydrochlorothiazide (25 mg) and amiloride (2·5 mg) in a combination tablet given twice daily gave better control of blood pressure in patients with mild to moderate essential hypertension than did equivalent dosages of timolol alone or of hydrochlorothiazide and amiloride. 4. Clinical and laboratory side effects were minimal.

Sign in / Sign up

Export Citation Format

Share Document